Ipca Laboratories Limited (BOM:524494)
India · Delayed Price · Currency is INR 1,309.90
+37.70 (2.96%)
At close: Nov 3, 2025
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2003 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2003 - 2019 |
Branded Generics | 44.62B | Log In | Log In | Log In | Log In | Upgrade |
Branded Generics Growth | 18.62% | Log In | Log In | Log In | Log In | Upgrade |
Generics | 29.29B | Log In | Log In | Log In | Log In | Upgrade |
Generics Growth | 23.69% | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients | 14.64B | Log In | Log In | Log In | Log In | Upgrade |
Active Pharmaceutical Ingredients Growth | -1.95% | Log In | Log In | Log In | Log In | Upgrade |
Export Incentives | 479.30M | Log In | Log In | Log In | Log In | Upgrade |
Export Incentives Growth | -1.32% | Log In | Log In | Log In | Log In | Upgrade |
Miscellaneous | 208.90M | Log In | Log In | Log In | Log In | Upgrade |
Miscellaneous Growth | 23.83% | Log In | Log In | Log In | Log In | Upgrade |
Scrap | 158.90M | Log In | Log In | Log In | Log In | Upgrade |
Scrap Growth | -3.93% | Log In | Log In | Log In | Log In | Upgrade |
Sundry Balances Written Back | 2.80M | Log In | Log In | Log In | Log In | Upgrade |
Sundry Balances Written Back Growth | -56.92% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2003 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2003 - 2019 |
India | 39.60B | Log In | Log In | Log In | Log In | Upgrade |
India Growth | 9.58% | Log In | Log In | Log In | Log In | Upgrade |
United States | 14.46B | Log In | Log In | Log In | Log In | Upgrade |
Europe | 13.88B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 58.05% | Log In | Log In | Log In | Log In | Upgrade |
Africa | 5.95B | Log In | Log In | Log In | Log In | Upgrade |
Africa Growth | 12.05% | Log In | Log In | Log In | Log In | Upgrade |
Americas | 4.64B | Log In | Log In | Log In | Log In | Upgrade |
Americas Growth | -65.83% | Log In | Log In | Log In | Log In | Upgrade |
Asia | 4.59B | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | -0.94% | Log In | Log In | Log In | Log In | Upgrade |
Australasia | 2.83B | Log In | Log In | Log In | Log In | Upgrade |
Australasia Growth | -8.39% | Log In | Log In | Log In | Log In | Upgrade |
Commonwealth of Independent States | 2.58B | Log In | Log In | Log In | Log In | Upgrade |
Commonwealth of Independent States Growth | 1.18% | Log In | Log In | Log In | Log In | Upgrade |
United Kingdom | - | Log In | Log In | Log In | Log In | Upgrade |
United Kingdom Growth | - | Log In | Log In | Log In | Log In | Upgrade |